Sudarshan Pharma Industries Ltd submits updated investor presentation, targeting minimum FY27 exports of ₹100 crore
- FY26 export turnover was ₹21.85 crore.
- The presentation, dated August 2026, outlines its pharmaceutical and specialty-chemicals businesses, subsidiaries and manufacturing capabilities.
- It also details expansion plans.
